ATYPICAL FIBROXANTHOMA - A STUDY OF 14 CASES EMPHASIZING THE PRESENCE OF LANGERHANS HISTIOCYTES WITH IMPLICATIONS FOR DIFFERENTIAL-DIAGNOSIS BY ANTIBODY PANELS
- 1 August 1988
- journal article
- research article
- Vol. 12 (8), 591-598
Abstract
Fourteen consecutive cases of atypical fibroxanthoma (AFX) seen during a 4-year period were studied histologically; of these, 12 were further examined for the presence of immunocytochemically detectable cytokeratin (CK), vimentin (VIM), S-100 protein, melanocyte-associated antigen (MAA), muscle-specific actin (MSA), alpha-l-antitrypsin (AIAT), alpha-l-antichymotrypsin (AIACT), and ferritin (FER). In four cases, electron microscopy was also performed. Tumor cells were nonreactive with antibodies directed against CK and MAA, strongly reactive with anti-VIM, and variably reactive with AIAT, AIACT, MSA, and FER. Our findings are consistent with the current notion that these tumors are "fibrohistiocytic". However, in 11 of 12 cases studied, a subpopulation of cells with features of Langerhans'' histiocytes (LH) was also identified. These were dendritic cells within the substance of the tumor that were strongly reactive with S-100 antibody and uniformly nonreactive with MAA antibody; ultrastructurally, they were seen to contain typical Birbeck granules. LH characteristically comprised no more than 5% of the overall cell population of the tumor; however, in restricted portions of some lesions, they sometimes accounted for up to 80% of tumor cells. The occurrence of LH in AFX, although previously reported, has not generally been emphasized. Awareness of their presence as an expected and sometimes extensive component of AFX can be important when interpreting differential immunocytochemical panels applied to malignant spindle cell tumors of skin.This publication has 18 references indexed in Scilit:
- Atypical fibroxanthoma. A study with antibody to S-100 proteinArchives of Dermatology, 1985
- Atypical fibroxanthoma distinguishable from spindle cell carcinoma in sarcoma-like skin lesions. A clinicopathologic and immunohistochemical study of 21 casesCancer, 1985
- Monoclonal antibody to cytokeratin for use in routine histopathology.Journal of Clinical Pathology, 1984
- MONOCLONAL-ANTIBODIES SPECIFIC FOR VIMENTIN1984
- Role of Antibody to S100 Protein in Diagnostic PathologyAmerican Journal of Clinical Pathology, 1983
- Correlation of specific keratins with different types of epithelial differentiation: Monoclonal antibody studiesCell, 1982
- The Use of Antiavidin Antibody and Avidin-Biotin-Peroxidase Complex in Immunoperoxidase TechnicsAmerican Journal of Clinical Pathology, 1981
- Atypical fibroxanthoma of the skin.An ultrastructural study of two casesCancer, 1977
- Malignant fibrous histiocytoma.An electron microscopic studyCancer, 1977
- Membranous basal cell adenoma of parotid gland, dermal cylindromas, and trichoepitheliomas:Comparative histochemistry and ultrastructureCancer, 1977